"As the market leader in the Benelux for pharmaceutical packaging and serialization, it was a natural fit to partner with TraceLink," said Eric Tjoa, CEO of Tjoapack. "Their Life Sciences Cloud allows us to provide our customers a cost-effective and agile track and trace solution, well ahead of the U.S. and EU deadlines, while continuing to guarantee we deliver the highest quality of services. We offer both standard and bespoke solutions to our customers and only TraceLink has been able to accommodate the tailored data needs associated with the nature of our business."
"The industry is beginning to place greater attention on EU FMD compliance, which introduces new complexities in serialization and government reporting. As a result, TraceLink is experiencing rapid customer adoption in Europe as companies realize that the proven Life Sciences Cloud platform provides them with an easy and fast path directly into the EU Hub," said Shabbir Dahod, president and CEO of TraceLink. "Tjoapack values our deep expertise on EU compliance and chose TraceLink to help achieve multiple country regulations for serialization, keep costs low and meet the complex data demands of their customers – whether they have to comply with DSCSA, EU FMD, or both."
Just 11 months from now, in November 2017, DSCSA regulations will require the serialization of all drug products and enhanced verification of product identity by pharmaceutical companies and their CMO/CPO partners. The first phase of this law, lot level tracing and verification, was enacted in January 2015. Since then, TraceLink has become the first and only solution provider to process over 170 million transaction history files for its customers.
Not far behind DSCSA, the EU FMD regulation will go into effect in 25 months, bringing considerable data management and business process challenges for organizations that do not have a comprehensive serialization strategy or the internal resources to cost-effectively build and maintain an architecture that can handle serialization. With the Life Sciences Cloud already integrated into the EU, TraceLink automatically facilitates serialized data for its customers into both the EU Hub and their national country databases. Additionally, TraceLink will begin hosting local data residency in the EU by early 2017, allowing global customers to utilize TraceLink's unique network-tenant platform approach to significantly reduce the time, cost and risk of achieving regulatory compliance and eliminate the need to verify and certify point-to-point connections to each government system.
To learn more about meeting global pharmaceutical compliance deadlines and how to build a flexible serialization, track and trace, and reporting platform for the U.S., the EU, China, Brazil, South Korea, India, Turkey, Argentina and other countries, please visit www.tracelink.com.
TraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
Tjoapack is the leading European pharmaceutical packaging specialist. Its distinctive focus on flexibility, patient safety, and supply chain innovation has been generating business successes for almost 30 years. Leading pharmaceutical companies continue to trust Tjoapack to deliver high quality services and provide invaluable insights into the increasingly changing supply chain landscape. Tjoapack has a long history of innovation with track and trace. In 1989 we were the first company in Europe to print barcodes on unit dose packages, paving the way for track and trace in hospitals and, in 2008, together with our partners, Tjoapack was the first in the world to develop full serialization and aggregation from blister pouch to pallet.
Tjoapack is determined to deliver customer oriented services and helping our clients preserve product integrity, mitigate risks, and reduce costs. For more information on Tjoapack and our services, visit www.tjoapack.com or follow us on LinkedIn.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tjoapack-selects-tracelink-to-achieve-dscsa--eu-fmd-compliance-for-its-eu-pharmaceutical-customers-300374217.html
SOURCE TraceLink Inc.